The Fort Worth Press - Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

USD -
AED 3.67315
AFN 63.503991
ALL 83.250403
AMD 377.180403
ANG 1.790083
AOA 917.000367
ARS 1385.524104
AUD 1.455996
AWG 1.8
AZN 1.70397
BAM 1.69972
BBD 2.014322
BDT 122.712716
BGN 1.709309
BHD 0.377014
BIF 2968.5
BMD 1
BND 1.28787
BOB 6.936019
BRL 5.267704
BSD 1.000117
BTN 94.794201
BWP 13.787919
BYN 2.976987
BYR 19600
BZD 2.011341
CAD 1.389055
CDF 2282.50392
CHF 0.797925
CLF 0.023434
CLP 925.320396
CNY 6.91185
CNH 6.92096
COP 3680.6
CRC 464.427092
CUC 1
CUP 26.5
CVE 96.12504
CZK 21.30604
DJF 177.720393
DKK 6.49183
DOP 59.72504
DZD 133.136429
EGP 52.703504
ERN 15
ETB 157.150392
EUR 0.86876
FJD 2.250504
FKP 0.749063
GBP 0.753835
GEL 2.69504
GGP 0.749063
GHS 10.97039
GIP 0.749063
GMD 73.503851
GNF 8780.000355
GTQ 7.653901
GYD 209.354875
HKD 7.83315
HNL 26.520388
HRK 6.545104
HTG 131.099243
HUF 339.295504
IDR 16969
ILS 3.13762
IMP 0.749063
INR 94.820704
IQD 1310
IRR 1313250.000352
ISK 124.760386
JEP 0.749063
JMD 157.422697
JOD 0.70904
JPY 160.341504
KES 129.903801
KGS 87.450384
KHR 4012.00035
KMF 428.00035
KPW 900.088302
KRW 1514.480383
KWD 0.30797
KYD 0.833446
KZT 483.490125
LAK 21900.000349
LBP 89550.000349
LKR 315.037957
LRD 183.625039
LSL 17.050381
LTL 2.95274
LVL 0.60489
LYD 6.380381
MAD 9.34038
MDL 17.566669
MGA 4175.000347
MKD 53.527547
MMK 2102.538494
MNT 3579.989157
MOP 8.069509
MRU 40.110379
MUR 46.703741
MVR 15.460378
MWK 1736.000345
MXN 18.119804
MYR 3.924039
MZN 63.910377
NAD 17.050377
NGN 1385.450377
NIO 36.720377
NOK 9.75706
NPR 151.667079
NZD 1.74221
OMR 0.384501
PAB 1.000109
PEN 3.459504
PGK 4.309504
PHP 60.502038
PKR 279.250374
PLN 3.724705
PYG 6538.855961
QAR 3.656504
RON 4.429038
RSD 101.983038
RUB 81.500035
RWF 1460
SAR 3.752265
SBD 8.041975
SCR 15.050419
SDG 601.000339
SEK 9.471805
SGD 1.288625
SHP 0.750259
SLE 24.550371
SLL 20969.510825
SOS 571.503662
SRD 37.601038
STD 20697.981008
STN 21.35
SVC 8.75063
SYP 110.526284
SZL 17.050369
THB 32.915504
TJS 9.556069
TMT 3.51
TND 2.923504
TOP 2.40776
TRY 44.460104
TTD 6.795201
TWD 31.999504
TZS 2576.487038
UAH 43.837189
UGX 3725.687866
UYU 40.481115
UZS 12190.000334
VES 466.018145
VND 26337.5
VUV 119.707184
WST 2.754834
XAF 570.070221
XAG 0.014334
XAU 0.000222
XCD 2.70255
XCG 1.802452
XDR 0.706792
XOF 566.503593
XPF 103.703591
YER 238.650363
ZAR 17.16735
ZMK 9001.203584
ZMW 18.826586
ZWL 321.999592
  • RBGPF

    -13.5000

    69

    -19.57%

  • RYCEF

    -0.6100

    14.69

    -4.15%

  • CMSC

    -0.0500

    22.77

    -0.22%

  • CMSD

    -0.0900

    22.66

    -0.4%

  • BCE

    -0.2200

    25.25

    -0.87%

  • NGG

    -0.4800

    81.92

    -0.59%

  • GSK

    -0.1000

    53.84

    -0.19%

  • RIO

    0.8500

    86.64

    +0.98%

  • RELX

    -0.1000

    31.97

    -0.31%

  • BTI

    0.3749

    57.8

    +0.65%

  • AZN

    5.0200

    188.42

    +2.66%

  • VOD

    -0.1400

    14.49

    -0.97%

  • BCC

    0.1400

    74.43

    +0.19%

  • JRI

    -0.2700

    11.8

    -2.29%

  • BP

    0.5100

    46.68

    +1.09%

Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence
Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

With the industry's largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation, and operational risk management.

Text size:

ATLANTA, GA / ACCESS Newswire / October 23, 2025 / Florence Healthcare reinforced its position as the global leader in clinical trial operations with a major milestone: Florence Trial Operations Platform now connects 65,000 study sites spanning more than 600 sponsors across 90+ countries, forming the industry's largest network. Recognized as the #1 clinical trial technology for six consecutive years, Florence continues to set the standard for startup speed, workflow automation, and operational risk management across sponsor study portfolios.

"Florence was built to bring sponsors and sites into a shared operational space," said Ryan Jones, CEO of Florence Healthcare. "First, we fully digitized startup to eliminate manual bottlenecks and paper workflows. Now, we're using AI to enhance speed and augment intelligence across 65,000 study sites globally - arming sponsors with portfolio-wide operational visibility so they can anticipate trial risk, act on insights, and drive execution on the ground."

Solving the $1 million per study problem

While digital-first sites set new standards for operational speed and efficiency, much of the industry still remains offline. Only 30% of global sites currently use an eISF, leaving roughly 200,000 sites dependent on inefficient paper processes for study startup, document collection and storage, regulatory process management, monitoring and closeout.

This lack of digitization costs sponsors an estimated $1 million per study in lost productivity, rework, quality and compliance risk.

Florence is closing this digital divide through the fastest growing clinical research network of 65,000 study sites and 600+ sponsors. By digitizing 100% of operational workflows, Florence sets the standard for startup speed, operational cost reduction, and risk control.

The results are compelling:

  • Up to 70% faster last mile study startup operations compared to the average site startup time for a Top 10 global pharmaceutical sponsor.

  • $141M annual operational cost takeout by automating site readiness workflows, based on active daily users and total hours saved per year across Florence's study site network.

  • 51% increase in eTMF QA pass rates from 65% to 98.7%, due to built-in operational audits and automated compliance checks to control risk.

Shaping the Future of Study Operations

Florence is embedding AI across the study lifecycle to unlock operational data intelligence, recommend next-best actions, strengthen risk control, and improve operating efficiency.

Site Identification & Feasibility

Drawing on the industry's largest network of site intelligence, Florence enables sponsors and CROs to identify the most qualified sites by therapeutic area, geography, and performance, while AI-assisted feasibility surveys ensure faster, more accurate completion.

Study Startup

AI-enabled contracting and document exchange between eTMF and eISF automates SSU document exchange, while generative AI redlining shortens contract review cycles, compares terms in seconds, and dramatically reduces time to activation.

Remote Monitoring

AI-powered reporting surfaces early risk signals from operational audit trails and site data, providing real-time visibility and enabling proactive intervention. These insights minimize the need for on-site visits and ensure trials stay on schedule.

Together, these advancements move sponsors and CROs from manual oversight to intelligent execution across global study portfolios. Through its open API network, Florence rapidly integrates and extends its trial operation capabilities to other eClinical partner systems.

Florence AI operates at the speed of trust, ensuring every study remains fully aligned with FDA, EMA, HIPAA, GDPR, EU Annex 11, ICH E6 (R3), and GCP standards.

All capabilities will be available in December 2025.

Join the Movement: Research Revolution 2025

Florence will showcase its newest capabilities at Research Revolution 2025, the company's annual global event (October 26-28, 2025) bringing together sponsors, CROs, and research sites. Be part of the global revolution. Watch it live at: https://researchrevolutionsummit.com/live/

About Florence Healthcare

Florence is a purpose-built platform that connects sponsors and sites to accelerate clinical trials, improve operational capacity, and reduce risk. Designed for scale, Florence streamlines workflows, enhances collaboration, and delivers real-time visibility across studies-empowering research teams to move faster, stay inspection-ready, and increase trial throughput with fewer resources.

Contact Information

Seema Sheth-Voss
[email protected]
(888) 829-0896

SOURCE: Florence Healthcare



View the original press release on ACCESS Newswire

L.Davila--TFWP